Expression of MHC class II-associated invariant chain (Ii;CD74) in thymic epithelial neoplasms

Applied Immunohistochemistry and Molecular Morphology

Volumn 8, Issue 3, 2000, Pages 210-215

  Datta, M W ^a   Shahsafaei, A ^a   Nadler, L M ^a   Freeman, G J ^a   Dorfman, D M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Immunohistochemistry; Thymic carcinoma; Thymoma; Thymus

Indexed keywords

CD5 ANTIGEN; CD74 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; DIAGNOSTIC VALUE; EPITHELIUM TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; THYMOMA;

ANTIGENS, CD5; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; GENES, MHC CLASS II; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; NEOPLASMS, GLANDULAR AND EPITHELIAL; PROTO-ONCOGENE PROTEINS C-BCL-2; THYMOMA; THYMUS NEOPLASMS;

EID: 0033844775     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-200009000-00007     Document Type: Article

References (24)

1. CD5 expression in thymic carcinoma
2. Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity
3. CD5 labeling of thymic carcinomas and other nonlymphoid neoplasms
4. Assembly, transport, and function of MHC class II molecules
5. Cell surface expression of human histocompatibility leucocyte antigen (HLA) class II-associated invariant chain (CD74) does not always correlate with cell-surface expression of HLA class II molecules
6. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens
7. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA
8. CD99 (p30/32MIC2) immunoreactivity in the diagnosis of thymic neoplasms and mediastinal lymphoproliferative disorders: A study of paraffin sections using monoclonal antibody O13
9. Developmental stages in the human thymus
10. Using thymus anatomy to dissect T cell repertoire selection
11. Antigenic phenotypes of hairy cell leukemia and monocytoid B-cell lymphoma: An immunohistochemical evaluation of 66 cases
12. Inconstancy of the immunophenotype of Reed-Sternberg cells in simultaneous and consecutive specimens from the same patients. A paraffin section evaluation in 56 patients
13. HLA-DM is expressed on the cell surface and colocalizes with HLA-DR and invariant chain in human Langerhans cells
14. Lamina propria macrophages in human gastrointestinal mucosa: Their distribution, immunohistological phenotype, and function
15. LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma
16. Lymphoid monoclonal antibodies reactive with lung tumors. Diagnostic applications
17. Cytokeratins in normal thymus and thymic epithelial tumors
18. Immunohistochemical localization of Mcl-1 and bcl-2 proteins in thymic epithelial tumors
19. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymic-like differentiation (CASTLE) and cervical thymic carcinoma
20. Thymic carcinoma. A clinicopathologic study of 13 cases
21. Thymic carcinomas: Histopathological varieties and immunohistochemical study
22. Characterization of the human thymic microenvironment: Lymphoepithelial interaction in normal thymus and thymoma
23. The MIC2 antibody O13. Practical application for the study of thymic epithelial tumors